Gene Transfer Study of ABO-102 in Patients With Middle and Advanced Phases of MPS IIIA Disease

Conditions:   MPS IIIA;   Sanfilippo Syndrome;   Sanfilippo A;   Mucopolysaccharidosis III Intervention:   Drug: ABO-102 Sponsor:   Abeona Therapeutics, Inc Not yet recruiting

Source: ClinicalTrials.gov - September 13, 2019 Category: Research Source Type: clinical trials